BioN­Tech, Du­al­i­ty­Bio of­fer first glimpse at part­nered ADC in sol­id tu­mors

Du­al­i­ty Bi­o­log­ics and BioN­Tech say in­ter­im da­ta on one of their part­nered AD­Cs look en­cour­ag­ing, with a pre­lim­i­nary cut from the tri­al show­ing that near­ly …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER